X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (284) 284
female (232) 232
middle aged (199) 199
male (186) 186
aged (164) 164
adult (127) 127
oncology (108) 108
aged, 80 and over (73) 73
survival (72) 72
risk factors (71) 71
treatment outcome (65) 65
surgery (64) 64
prognosis (61) 61
follow-up studies (51) 51
analysis (50) 50
retrospective studies (50) 50
cancer (47) 47
survival analysis (43) 43
netherlands (42) 42
care and treatment (41) 41
breast cancer (38) 38
chemotherapy (36) 36
neoplasm staging (36) 36
quality of life (35) 35
statistics & probability (35) 35
surveys and questionnaires (34) 34
time factors (34) 34
health aspects (32) 32
patients (32) 32
mortality (31) 31
proportional hazards models (31) 31
transplantation (31) 31
women (31) 31
colorectal cancer (30) 30
medicine & public health (30) 30
risk (30) 30
quality-of-life (29) 29
abridged index medicus (28) 28
carcinoma (28) 28
research (28) 28
recurrence (27) 27
young adult (27) 27
breast neoplasms - drug therapy (26) 26
breast neoplasms - pathology (26) 26
diagnosis (26) 26
prospective studies (26) 26
cardiac & cardiovascular systems (25) 25
tumors (25) 25
competing risks (24) 24
cross-sectional studies (24) 24
disease-free survival (24) 24
mathematical & computational biology (24) 24
netherlands - epidemiology (24) 24
risk assessment (24) 24
urology & nephrology (24) 24
cancer research (23) 23
multivariate analysis (23) 23
chemotherapy, adjuvant (22) 22
hematology, oncology and palliative medicine (22) 22
breast neoplasms - mortality (21) 21
medical research (21) 21
outcomes (21) 21
radiotherapy (21) 21
therapy (21) 21
adolescent (20) 20
genetics (20) 20
immunohistochemistry (20) 20
survival rate (20) 20
association (19) 19
dna methylation (19) 19
management (19) 19
medicine, research & experimental (19) 19
studies (19) 19
clinical trials (18) 18
cohort studies (18) 18
epidemiology (18) 18
patient outcomes (18) 18
prevalence (18) 18
total mesorectal excision (18) 18
usage (18) 18
disease (17) 17
impact (17) 17
incidence (17) 17
medical informatics (17) 17
medicine (17) 17
models, statistical (17) 17
public, environmental & occupational health (17) 17
research article (17) 17
immunology (16) 16
kaplan-meier estimate (16) 16
radiology, nuclear medicine & medical imaging (16) 16
sexual disorders (16) 16
umcg approved (16) 16
cancer patients (15) 15
child (15) 15
disease progression (15) 15
europe (15) 15
expression (15) 15
postmenopausal women (15) 15
rectal neoplasms - pathology (15) 15
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Statistics in medicine, ISSN 1097-0258, 2019, Volume 38, Issue 18, pp. 3405 - 3420
Multivariate survival data are frequently encountered in biomedical applications in the form of clustered failures (or recurrent events data). A popular way of... 
frailty | unobserved heterogeneity | proportional hazards | REGRESSION | MEDICINE, RESEARCH & EXPERIMENTAL | TESTS | PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH | MODELS | MEDICAL INFORMATICS | MATHEMATICAL & COMPUTATIONAL BIOLOGY | STATISTICS & PROBABILITY
Journal Article
The Lancet (British edition), ISSN 0140-6736, 2011, Volume 377, Issue 9762, pp. 321 - 331
Journal Article
The lancet oncology, ISSN 1470-2045, 2016, Volume 17, Issue 8, pp. 1114 - 1126
Summary Background About 15% of patients with endometrial cancer have high-risk features and are at increased risk of distant metastases and endometrial... 
Hematology, Oncology and Palliative Medicine | CARCINOMA PATIENTS | EXTERNAL-BEAM RADIOTHERAPY | GYNECOLOGIC-ONCOLOGY-GROUP | ONCOLOGY | PELVIC RADIATION-THERAPY | EUROPEAN-ORGANIZATION | STAGE-I | OVARIAN-CANCER | INTERMEDIATE-RISK | III TRIAL | CHEMOTHERAPY | Endometrial Neoplasms - radiotherapy | Prognosis | Follow-Up Studies | Humans | Middle Aged | Gastrointestinal Diseases - etiology | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Adenocarcinoma, Clear Cell - radiotherapy | Chemoradiotherapy, Adjuvant - adverse effects | Nervous System Diseases - diagnosis | Case-Control Studies | Gastrointestinal Diseases - diagnosis | Cisplatin - administration & dosage | Neoplasm Grading | Radiotherapy, Adjuvant - adverse effects | Cystadenocarcinoma, Serous - therapy | Female | Paclitaxel - administration & dosage | Cystadenocarcinoma, Serous - secondary | Neoplasm Invasiveness | Carboplatin - administration & dosage | Survival Rate | Lymphatic Metastasis | Hematologic Diseases - diagnosis | Adenocarcinoma, Clear Cell - secondary | Hematologic Diseases - etiology | Adenocarcinoma, Clear Cell - therapy | Endometrial Neoplasms - therapy | Nervous System Diseases - etiology | Quality of Life | Endometrial Neoplasms - pathology | Aged | Neoplasm Staging | Cystadenocarcinoma, Serous - radiotherapy | Endometrial cancer | Oncology, Experimental | Radiation | Metastasis | Research | Radiotherapy | Health aspects | Risk factors | Cancer
Journal Article
Journal Article
Journal Article
The lancet oncology, ISSN 1470-2045, 2019, Volume 20, Issue 9, pp. 1273 - 1285
SummaryBackgroundThe PORTEC-3 trial investigated the benefit of combined adjuvant chemotherapy and radiotherapy versus pelvic radiotherapy alone for women with... 
Hematology, Oncology, and Palliative Medicine | CARCINOMA PATIENTS | IRRADIATION | MULTICENTER | THERAPY | ONCOLOGY | OPEN-LABEL | RADIATION | III TRIAL | CHEMOTHERAPY | Endometrial cancer | Radiotherapy | Health aspects | Risk factors
Journal Article